Company / Depreciation & Amortization
Bio-Techne Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$109.9M
FY2025
5-year range
$78.2M / $111.7M
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
#64 of 142
Health Care
What the data says
At $110M, Bio-Techne's depreciation & amortization ranks #79 of 142 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 10 years, ranging from $43M in FY2016 to $112M in FY2024.
Based on SEC 10-K filings.
$110M in FY2025 with a 5-year CAGR of +5.8%.
Increased from $88M to $110M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +9.9%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Sector benchmark
#79 of 142 in Health CareTop 55% of 142This company $109.9M Sector average $347.4M
▼
-68.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 1.6% year-over-year.
- Ranks #64 out of 142 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $109.9M | -1.6% |
| FY2024 | $111.7M | +27.3% |
| FY2023 | $87.7M | +6.1% |
| FY2022 | $82.7M | +5.8% |
| FY2021 | $78.2M | -5.5% |
| FY2020 | $82.7M | +5.8% |
| FY2019 | $78.2M | +21.3% |
| FY2018 | $64.5M | +7.4% |
| FY2017 | $60.0M | +40.4% |
| FY2016 | $42.8M | +14.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026